Xeris Biopharma Holdings, Inc. today announced it expects to generate total 2024 revenue of $203 million, which will exceed previously announced 2024 total revenue guidance of $198 million to $202 ...
Details: Randomized, double-blind, placebo-controlled trial involving 338 outpatients with MDD, conducted over an 8-week monotherapy period (250mg BID). Initial results from the OLIVE trial are ...
Pairzon is excited to unveil our enhanced Media Mix Modeling solution, designed to transform how retail marketers optimize marketing efforts across online and offline channels. In today's competitive ...